Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study.
about
Dietary and nutritional considerations for inflammatory bowel diseaseSystematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseasesEfficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to datePotential Benefits of Dietary Fibre Intervention in Inflammatory Bowel DiseaseThe intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsModulating Composition and Metabolic Activity of the Gut Microbiota in IBD PatientsOverlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?Diet therapy for inflammatory bowel diseases: The established and the newDiet and inflammatory bowel disease: review of patient-targeted recommendationsReview article: the aetiology, diagnosis, mechanisms and clinical evidence for food intoleranceThe Role of Diet in Inflammatory Bowel Disease.Mechanisms and efficacy of dietary FODMAP restriction in IBS.Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis.Fermentable carbohydrates (FODMAPs) exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial.Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel diseaseThe microbiota in inflammatory bowel disease: current and therapeutic insightsConvergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.Dietary fructose intolerance, fructan intolerance and FODMAPs.Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome.The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic Review.Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.Short-chain carbohydrates and functional gastrointestinal disorders.Review article: evidence-based dietary advice for patients with inflammatory bowel disease.Popular exclusionary diets for inflammatory bowel disease: the search for a dietary culprit.Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease.British Dietetic Association evidence-based guidelines for the dietary management of Crohn's disease in adults.Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases.Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis.Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaireNovel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiologyLow-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial.Nutritional management of Crohn's disease.Diet and Inflammatory Bowel Disease.Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined DietsCandidate genes involved in beneficial or adverse responses to commonly eaten brassica vegetables in a New Zealand Crohn's disease cohort.An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease.Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status.Food intolerance in functional bowel disorders.
P2860
Q22251396-1332E0D5-56E3-4889-ACBB-B4EAA17C17E0Q26740495-BF587CE8-5CE7-416A-B885-30D4DA8E2B1BQ26744329-5F7B03A7-0231-4267-AE53-C651A6C5147FQ26744514-5AD2EFF1-3713-47B7-B070-6C3502F770B5Q26745700-25485478-A5A4-4449-9B34-BBB4D6A6F051Q26750985-71A24A26-1A57-4C15-937E-79AEA9BF0D75Q26765219-E5D2A150-CBCF-4A18-9D16-00B41EF954E0Q26768564-C52FC0B4-F760-423D-A7E8-D6C8F74CB4FDQ26823435-61DA7BA6-6BA1-4BD8-BE5B-A31C4F37A16FQ27025168-3C613526-D433-4735-994E-1C2681D36B52Q30234868-8B7E2069-EDB3-43C9-AAFD-7E955A92D377Q30738587-470A3E5D-5E74-4A74-A4A7-9563FE3023DFQ33450566-CE9A0767-3530-432E-A5E5-86756CA45517Q33458071-AE439B74-4E99-4438-BB0D-83943D08009EQ33465076-E00FDD57-6B81-4704-9330-0EDC004AD33DQ33470528-D2F5AF07-8D0D-4ABD-9142-553B03BD9563Q33696448-70DF5856-8808-4DED-A82E-35F2261ADB70Q33806817-B2F1C2B8-7D3B-4495-B088-404BC4E4E840Q33958801-614B9BC8-D8D1-4C1C-99AE-A0920E69A72AQ34393301-8369DD7C-6E0F-4851-AA22-B20B78EB8426Q34420107-64566488-707E-4781-B9D3-57618B96831AQ34457261-9576C1C7-373B-4524-BC60-48AE5E1B57E3Q34522949-B3A9AFEA-8B20-4CE5-95A6-B7AA58B34D80Q34650473-5EEEB32B-8F79-459F-B116-A4DB958069F0Q34656566-934BA96B-AA3A-456B-AC93-30236DB9F0D4Q34659893-DC99950E-6B20-4F0A-AE39-9890B66E1224Q35015511-78DD4014-AB4E-48E3-9B34-6B7E37F77833Q35061688-E0F6974D-27E1-4CE9-9ECF-BEAC3799A4A3Q35090776-115260C2-5D7C-40E1-8D80-1DCBC5891CD0Q35196243-23E7ABC0-E0EC-48D5-BB52-B3461A1541E2Q35225660-D29812D8-C13A-4B7D-AD8A-4B93E95F25E2Q36245600-87382005-4B23-4E3F-9293-706E893CDB61Q36246372-25F74659-55EA-43FF-B68A-CAB4CF654B20Q36761878-ED471148-244E-4F0A-9533-2A4BA6EF2BF3Q36830446-C6A0B974-1FFB-408B-8D7F-7681925E2B86Q36864735-3B8BE825-DB31-4D1A-839A-DBCB4622D0DEQ37420522-4CDAE610-13EF-4E3B-ABC1-1095BAF3FDC0Q37729775-912827F5-94C2-4CFA-996D-252F53629435Q37826807-0FDA0641-FBB7-4323-8D52-B8508F428BA9Q37858653-92B88836-A756-4016-B1F8-052E8C2FF824
P2860
Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Reduction of dietary poorly ab ...... y bowel disease-a pilot study.
@ast
Reduction of dietary poorly ab ...... y bowel disease-a pilot study.
@en
Reduction of dietary poorly absorbed short-chain carbohydrates
@nl
type
label
Reduction of dietary poorly ab ...... y bowel disease-a pilot study.
@ast
Reduction of dietary poorly ab ...... y bowel disease-a pilot study.
@en
Reduction of dietary poorly absorbed short-chain carbohydrates
@nl
prefLabel
Reduction of dietary poorly ab ...... y bowel disease-a pilot study.
@ast
Reduction of dietary poorly ab ...... y bowel disease-a pilot study.
@en
Reduction of dietary poorly absorbed short-chain carbohydrates
@nl
P2093
P2860
P1476
Reduction of dietary poorly ab ...... ry bowel disease-a pilot study
@en
P2093
Debbie M Nathan
Jacqueline S Barrett
Peter M Irving
Peter R Gibson
Sue J Shepherd
P2860
P356
10.1016/J.CROHNS.2008.09.004
P577
2008-12-06T00:00:00Z